These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 27013134)

  • 1. Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2.
    Moon JS; Lee SH; Han SH; Kim EJ; Cho H; Lee W; Kim MK; Kim TE; Park HJ; Rhee JK; Kim SJ; Cho SW; Han SH; Oh JW
    Nanomedicine; 2016 Aug; 12(6):1489-98. PubMed ID: 27013134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation.
    Kim SJ; Kim JH; Kim YG; Lim HS; Oh JW
    J Biol Chem; 2004 Nov; 279(48):50031-41. PubMed ID: 15364941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.
    Moon JS; Lee SH; Kim EJ; Cho H; Lee W; Kim GW; Park HJ; Cho SW; Lee C; Oh JW
    PLoS One; 2016; 11(1):e0146710. PubMed ID: 26751678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase.
    Kim SJ; Kim JH; Sun JM; Kim MG; Oh JW
    J Viral Hepat; 2009 Oct; 16(10):697-704. PubMed ID: 19243496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Target delivery of small interfering RNAs with vitamin E- loaded lipid nanoparticles in inhibition of hepatitis C virus core protein expression in mouse model].
    Ye YY; Chen H; Yan Y; Chen L; Huang WX
    Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):382-387. PubMed ID: 29996208
    [No Abstract]   [Full Text] [Related]  

  • 7. Destabilization of PDK1 by Hsp90 inactivation suppresses hepatitis C virus replication through inhibition of PRK2-mediated viral RNA polymerase phosphorylation.
    Kim MG; Moon JS; Kim EJ; Lee SH; Oh JW
    Biochem Biophys Res Commun; 2012 Apr; 421(1):112-8. PubMed ID: 22490666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs.
    Chang B; Lee CH; Lee JH; Lee SW
    Biotechnol Lett; 2010 Sep; 32(9):1231-7. PubMed ID: 20464448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
    Ng TI; Mo H; Pilot-Matias T; He Y; Koev G; Krishnan P; Mondal R; Pithawalla R; He W; Dekhtyar T; Packer J; Schurdak M; Molla A
    Hepatology; 2007 Jun; 45(6):1413-21. PubMed ID: 17518369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
    Halfon P; Sarrazin C
    Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
    Bukh J
    J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of hepatitis C virus replication by small interfering RNA in cells infected by HCV].
    Xing XK; He JL; Chen Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 40(6):582-7. PubMed ID: 22190516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus resistance to protease inhibitors.
    Halfon P; Locarnini S
    J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C.
    Duan L; Yan Y; Liu J; Wang B; Li P; Hu Q; Chen W
    Sci Rep; 2016 Apr; 6():24867. PubMed ID: 27113197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery-mediated control of RNA immunostimulation.
    Nguyen DN; Chen SC; Lu J; Goldberg M; Kim P; Sprague A; Novobrantseva T; Sherman J; Shulga-Morskaya S; de Fougerolles A; Chen J; Langer R; Anderson DG
    Mol Ther; 2009 Sep; 17(9):1555-62. PubMed ID: 19584813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulated minimal-length synthetic small hairpin RNAs are potent inhibitors of hepatitis C virus in mice with humanized livers.
    Ma H; Dallas A; Ilves H; Shorenstein J; MacLachlan I; Klumpp K; Johnston BH
    Gastroenterology; 2014 Jan; 146(1):63-6.e5. PubMed ID: 24076507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of siRNAs against La Autoantigen with NS5B or hVAP-A Have Additive Effect on Inhibition of HCV Replication.
    Mandal A; Ganta KK; Chaubey B
    Hepat Res Treat; 2016; 2016():9671031. PubMed ID: 27446609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.
    Park HJ; Jeon EJ; Lee JS; Hong SH; Cho AN; Lee J; Moon JS; Jung KE; Oh JW; Lee H; Cho SW
    Adv Healthc Mater; 2016 Nov; 5(22):2931-2941. PubMed ID: 27774775
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.